Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00411684 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of CDB-2914 for Emergency Contraception
A Phase 3 study of Emergency Contraception, sponsored by HRA Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,623
- Enrollment target
- 17
- Study locations
NCT00411684 is a Phase 3 study of Emergency Contraception that has completed, run by HRA Pharma. The registered enrollment target is 1,623 participants, above the 1,164-participant average among 3 other Emergency Contraception trials with a reported enrollment target (39% higher). The trial reports 17 study locations across 15 states.
The verdict
NCT00411684, a Phase 3 study of Emergency Contraception, has completed, sponsored by HRA Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,623 participants
- Enrollment target
- 17
- Study locations
Study Summary
The purpose of this study is to assess the safety and efficacy of CDB-2914 for preventing pregnancy when taken 3 to 5 days after unprotected sexual intercourse.
Conditions Studied
Interventions
- DRUG CDB-2914
Study Locations (17)
Florida
- Planned Parenthood of Greater Miami, Palm Beach and Treasure Cost - Miami
- Planned Parenthood of South Palm Beach, Pembroke Pines - Pembroke Pines
Texas
- Planned Parenthood of the Texas Capital Region - Austin
- Planned Parenthood of Houston and Southeast Texas - Houston
California
- Planned Parenthood of Mar Monte - San Jose
Colorado
- Planned Parenthood of the Rocky Mountains - Denver
Indiana
- Planned Parenthood of Indiana - Bloomington
Iowa
- Planned Parenthood of Greater Iowa - Ames
Maryland
- Planned Parenthood of Maryland - Baltimore
Massachusetts
- Planned Parenthood League of Massachusetts - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,623 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-06-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00411684
The ClinicalTrials.gov registry entry for NCT00411684 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,623 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,164-participant average among 3 other Emergency Contraception trials with a reported enrollment target (39% higher). The listed sponsor is HRA Pharma, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Emergency Contraception appearing as the primary indexed condition, and to 1 intervention - of which CDB-2914 is the first listed.
NCT00411684 reports 17 study locations spanning 15 distinct geographic areas - top geographies include Florida, Texas, California.
Frequently Asked Questions
What is clinical trial NCT00411684 about?
NCT00411684 is a clinical study titled "Safety and Efficacy of CDB-2914 for Emergency Contraception". The purpose of this study is to assess the safety and efficacy of CDB-2914 for preventing pregnancy when taken 3 to 5 days after unprotected sexual intercourse.
What is the current status of trial NCT00411684?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,623 participants. The study started on 2006-11. Estimated completion is 2009-06-05.
What conditions does trial NCT00411684 study?
This clinical trial studies the following conditions: Emergency Contraception.
What interventions are being tested in trial NCT00411684?
The interventions under investigation include: CDB-2914 (DRUG).
Who is sponsoring clinical trial NCT00411684?
This trial is sponsored by HRA Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00411684 being conducted?
This trial has 17 study locations across California, Colorado, Florida, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emergency Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.